vs
Astrana Health, Inc.（ASTH）与Tyler Technologies（TYL）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是Tyler Technologies的1.7倍（$950.5M vs $575.2M），Tyler Technologies净利率更高（11.4% vs 0.7%，领先10.7%），Astrana Health, Inc.同比增速更快（42.9% vs 6.3%），Tyler Technologies自由现金流更多（$239.6M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 6.0%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
Tyler Technologies, Inc.是总部位于美国得克萨斯州普莱诺的科技企业，主营面向美国公共部门提供自研专有软件，目前在全美17个州设有办事处，另在加拿大安大略省多伦多市设有一处办公网点。
ASTH vs TYL — 直观对比
营收规模更大
ASTH
是对方的1.7倍
$575.2M
营收增速更快
ASTH
高出36.6%
6.3%
净利率更高
TYL
高出10.7%
0.7%
自由现金流更多
TYL
多$245.5M
$-6.0M
两年增速更快
ASTH
近两年复合增速
6.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $575.2M |
| 净利润 | $6.6M | $65.5M |
| 毛利率 | — | 45.5% |
| 营业利润率 | 1.9% | 13.0% |
| 净利率 | 0.7% | 11.4% |
| 营收同比 | 42.9% | 6.3% |
| 净利润同比 | 184.4% | 0.5% |
| 每股收益（稀释后） | $0.12 | $1.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHTYL
| Q4 25 | $950.5M | $575.2M | ||
| Q3 25 | $956.0M | $595.9M | ||
| Q2 25 | $654.8M | $596.1M | ||
| Q1 25 | $620.4M | $565.2M | ||
| Q4 24 | $665.2M | $541.1M | ||
| Q3 24 | $478.7M | $543.3M | ||
| Q2 24 | $486.3M | $541.0M | ||
| Q1 24 | $404.4M | $512.4M |
净利润ASTHTYL
| Q4 25 | $6.6M | $65.5M | ||
| Q3 25 | $373.0K | $84.4M | ||
| Q2 25 | $9.4M | $84.6M | ||
| Q1 25 | $6.7M | $81.1M | ||
| Q4 24 | $-7.8M | $65.2M | ||
| Q3 24 | $16.1M | $75.9M | ||
| Q2 24 | $19.2M | $67.7M | ||
| Q1 24 | $14.8M | $54.2M |
毛利率ASTHTYL
| Q4 25 | — | 45.5% | ||
| Q3 25 | — | 47.2% | ||
| Q2 25 | — | 45.8% | ||
| Q1 25 | — | 47.3% | ||
| Q4 24 | — | 43.8% | ||
| Q3 24 | — | 43.7% | ||
| Q2 24 | — | 44.0% | ||
| Q1 24 | — | 43.7% |
营业利润率ASTHTYL
| Q4 25 | 1.9% | 13.0% | ||
| Q3 25 | 2.0% | 16.4% | ||
| Q2 25 | 3.1% | 16.0% | ||
| Q1 25 | 3.3% | 15.8% | ||
| Q4 24 | 0.1% | 13.2% | ||
| Q3 24 | 5.9% | 15.2% | ||
| Q2 24 | 6.2% | 14.4% | ||
| Q1 24 | 7.5% | 13.1% |
净利率ASTHTYL
| Q4 25 | 0.7% | 11.4% | ||
| Q3 25 | 0.0% | 14.2% | ||
| Q2 25 | 1.4% | 14.2% | ||
| Q1 25 | 1.1% | 14.3% | ||
| Q4 24 | -1.2% | 12.1% | ||
| Q3 24 | 3.4% | 14.0% | ||
| Q2 24 | 3.9% | 12.5% | ||
| Q1 24 | 3.7% | 10.6% |
每股收益（稀释后）ASTHTYL
| Q4 25 | $0.12 | $1.50 | ||
| Q3 25 | $0.01 | $1.93 | ||
| Q2 25 | $0.19 | $1.93 | ||
| Q1 25 | $0.14 | $1.84 | ||
| Q4 24 | $-0.14 | $1.48 | ||
| Q3 24 | $0.33 | $1.74 | ||
| Q2 24 | $0.40 | $1.57 | ||
| Q1 24 | $0.31 | $1.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $1.1B |
| 总债务越低越好 | — | $599.7M |
| 股东权益账面价值 | $779.3M | $3.7B |
| 总资产 | $2.2B | $5.6B |
| 负债/权益比越低杠杆越低 | — | 0.16× |
8季度趋势，按日历期对齐
现金及短期投资ASTHTYL
| Q4 25 | $429.5M | $1.1B | ||
| Q3 25 | $463.4M | $950.8M | ||
| Q2 25 | $342.1M | $892.3M | ||
| Q1 25 | $260.9M | $807.4M | ||
| Q4 24 | $290.8M | $768.0M | ||
| Q3 24 | $350.3M | $544.3M | ||
| Q2 24 | $327.7M | $258.0M | ||
| Q1 24 | $337.3M | $196.9M |
总债务ASTHTYL
| Q4 25 | — | $599.7M | ||
| Q3 25 | — | $599.2M | ||
| Q2 25 | — | $598.8M | ||
| Q1 25 | — | $598.4M | ||
| Q4 24 | — | $597.9M | ||
| Q3 24 | — | $597.5M | ||
| Q2 24 | — | $597.1M | ||
| Q1 24 | — | $596.6M |
股东权益ASTHTYL
| Q4 25 | $779.3M | $3.7B | ||
| Q3 25 | $775.5M | $3.6B | ||
| Q2 25 | $765.5M | $3.6B | ||
| Q1 25 | $745.4M | $3.5B | ||
| Q4 24 | $712.7M | $3.4B | ||
| Q3 24 | $704.6M | $3.3B | ||
| Q2 24 | $678.9M | $3.1B | ||
| Q1 24 | $653.5M | $3.0B |
总资产ASTHTYL
| Q4 25 | $2.2B | $5.6B | ||
| Q3 25 | $2.2B | $5.5B | ||
| Q2 25 | $1.4B | $5.4B | ||
| Q1 25 | $1.3B | $5.2B | ||
| Q4 24 | $1.4B | $5.2B | ||
| Q3 24 | $1.3B | $5.0B | ||
| Q2 24 | $1.3B | $4.8B | ||
| Q1 24 | $1.2B | $4.6B |
负债/权益比ASTHTYL
| Q4 25 | — | 0.16× | ||
| Q3 25 | — | 0.17× | ||
| Q2 25 | — | 0.16× | ||
| Q1 25 | — | 0.17× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.18× | ||
| Q2 24 | — | 0.19× | ||
| Q1 24 | — | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $243.9M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $239.6M |
| 自由现金流率自由现金流/营收 | -0.6% | 41.7% |
| 资本支出强度资本支出/营收 | 0.3% | 0.8% |
| 现金转化率经营现金流/净利润 | -0.44× | 3.72× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $637.5M |
8季度趋势，按日历期对齐
经营现金流ASTHTYL
| Q4 25 | $-2.9M | $243.9M | ||
| Q3 25 | $10.0M | $255.2M | ||
| Q2 25 | $90.9M | $98.3M | ||
| Q1 25 | $16.6M | $56.2M | ||
| Q4 24 | $-10.9M | $224.8M | ||
| Q3 24 | $34.0M | $263.7M | ||
| Q2 24 | $23.2M | $64.3M | ||
| Q1 24 | $6.0M | $71.8M |
自由现金流ASTHTYL
| Q4 25 | $-6.0M | $239.6M | ||
| Q3 25 | $7.4M | $251.3M | ||
| Q2 25 | $89.5M | $92.8M | ||
| Q1 25 | $13.6M | $53.8M | ||
| Q4 24 | $-13.5M | $221.0M | ||
| Q3 24 | $31.7M | $260.8M | ||
| Q2 24 | $20.4M | $57.7M | ||
| Q1 24 | $5.6M | $64.6M |
自由现金流率ASTHTYL
| Q4 25 | -0.6% | 41.7% | ||
| Q3 25 | 0.8% | 42.2% | ||
| Q2 25 | 13.7% | 15.6% | ||
| Q1 25 | 2.2% | 9.5% | ||
| Q4 24 | -2.0% | 40.8% | ||
| Q3 24 | 6.6% | 48.0% | ||
| Q2 24 | 4.2% | 10.7% | ||
| Q1 24 | 1.4% | 12.6% |
资本支出强度ASTHTYL
| Q4 25 | 0.3% | 0.8% | ||
| Q3 25 | 0.3% | 0.7% | ||
| Q2 25 | 0.2% | 0.9% | ||
| Q1 25 | 0.5% | 0.4% | ||
| Q4 24 | 0.4% | 0.7% | ||
| Q3 24 | 0.5% | 0.5% | ||
| Q2 24 | 0.6% | 1.2% | ||
| Q1 24 | 0.1% | 1.4% |
现金转化率ASTHTYL
| Q4 25 | -0.44× | 3.72× | ||
| Q3 25 | 26.69× | 3.02× | ||
| Q2 25 | 9.65× | 1.16× | ||
| Q1 25 | 2.48× | 0.69× | ||
| Q4 24 | — | 3.45× | ||
| Q3 24 | 2.11× | 3.47× | ||
| Q2 24 | 1.21× | 0.95× | ||
| Q1 24 | 0.40× | 1.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
TYL
| Saas Arrangements | $186.1M | 32% |
| Platform Technologies Segment | $143.3M | 25% |
| Maintenance | $109.4M | 19% |
| Professional Services | $55.3M | 10% |
| Nonrecurring Revenue | $51.3M | 9% |
| Other | $21.4M | 4% |
| Hardware And Other | $8.4M | 1% |
